Related by context. All words. (Click for frequent words.) 78 3 X ULN 74 X ULN 74 hepatic transaminase levels 73 liver transaminases 72 serum aminotransferases ALT 69 transaminases 67 aminotransferases 67 alanine aminotransferase 66 baseline serum creatinine 66 serum aminotransferase levels 65 aminotransferase levels 65 aminotransferase ALT 65 Scale EDSS score 65 transaminase 65 elevated ALT 64 SGPT 64 hypophosphatemia 64 aspartate aminotransferase 64 aspartate aminotransferase AST 64 CrCl 64 moderate renal impairment 63 hepatic enzyme 63 serum phosphate 63 CK MB 63 Fasting blood glucose 63 x ULN 63 SGOT 63 leucopenia 63 elevated serum creatinine 62 serum ALT 62 neutropenia thrombocytopenia 62 transaminase elevations 62 alanine aminotransferase ALT 62 ALT elevation 62 urinary albumin 62 transaminase levels 62 serum homocysteine 62 Erythropoietic therapies may 62 REYATAZ r arm 62 normal ULN 62 AST ALT 62 del 5q MDS 61 Proteinuria 61 serum leptin 61 macroalbuminuria 61 TEAEs 61 anemia hemoglobin 61 Index CDAI 61 lopinavir r arm 61 epithermal pathfinder elements 61 bilirubin liver 61 #.#mg/dL 61 arterial thromboembolic events 61 Expanded Disability Status 60 urinary calcium 60 alanine transaminase 60 serum magnesium 60 potassic altered porphyry 60 aminotransferase elevations greater 60 ALT elevations 60 total cholesterol LDL 60 serum HBV DNA 60 hepatic enzymes 60 serum potassium 60 nonfasting triglycerides 60 CDAI score 60 plasma HCV RNA 60 serum triglyceride levels 60 Prehypertension 60 severe exacerbations 60 serum prostate 60 extrapyramidal symptoms 60 TAXUS p value 60 leukopenia 60 serum uric acid 60 serum potassium levels 60 Crohn Disease Activity 60 lipoprotein Lp 59 See WARNINGS 59 renal impairment 59 pulmonary exacerbations 59 hypercalcemia 59 serum creatinine levels 59 kidney toxicity nephrotoxicity 59 quetiapine XR 59 serum urate 59 hypoglycemic events 59 DAS# CRP 59 XIENCE V PROMUS Stent 59 intact parathyroid hormone 59 receiving XGEVA 59 serum IGF 59 severe neutropenia 59 definite stent thrombosis 59 hyperhomocysteinemia 59 receiving INTRON 59 oxycodone CR 59 thromboembolic events 59 rhinoconjunctivitis 59 proteinuria 59 airflow limitation 59 mild renal impairment 59 creatine kinase CK 59 triglycerides TG 58 annualized relapse 58 lactate dehydrogenase LDH 58 elevated triglycerides 58 ng dL 58 CHD CVD 58 creatinine clearance 58 triglyceride TG 58 ALT AST 58 Albuminuria 58 serum urate levels 58 PROCTOCORT ® Suppository Hydrocortisone 58 serum triglycerides 58 abdominal adiposity 58 mmHg diastolic 58 Scale EDSS 58 Low Density Lipoprotein Cholesterol 58 left ventricular diastolic 58 left ventricular hypertrophy 58 cholesterol LDL C 58 mcg mL 58 MIC# [001] 58 hip BMD 58 creatine kinase MB 58 elevated triglyceride levels 58 -#.# mg dL [002] 58 sUA 58 total cholesterol triglycerides 58 atherogenic dyslipidemia 58 coronary stenosis 58 CCyR 58 urine albumin 58 intracranial hemorrhage ICH 58 achieved ACR# 58 hyperphenylalaninemia HPA due 58 mild renal insufficiency 58 linaclotide treated 58 Infusion Reactions Severe 58 serum testosterone 58 log# copies mL 58 urinary oxalate 58 DAS# remission 58 lumbar spine bone 58 PASI scores 58 Intraocular Pressure 58 plasma homocysteine 58 hyperphosphatemia elevated serum phosphorous 58 plasma triglycerides 58 Psoriasis Area 57 Skin sterol 57 bone marrow reticulin 57 baseline FEV 57 systemic corticosteroid 57 serum folate 57 elevated IOP 57 mg BID dose 57 lipid elevations 57 deep venous thromboses 57 breccias containing 57 nasopharyngitis headache 57 laboratory abnormalities 57 lactate dehydrogenase 57 hypokalemia 57 relapsed MM 57 serum LDL cholesterol 57 mcg kg REBETOL 57 8mg/kg 57 autoantibody positive 57 glycosylated hemoglobin HbA1c 57 PSA nadir 57 â ‰ ¥ 57 4mg/kg 57 hypercholesterolaemia 57 mU liter 57 mEq L 57 glycated hemoglobin levels 57 μg L 57 diastolic blood pressures 57 serum cortisol 57 serum CRP 57 Kaplan Meier estimates 57 Alzheimer disease vascular dementia 57 cTnT 57 EDSS scores 57 hypopneas 57 #mg/dL [001] 57 PREZISTA r arm 57 undetectable viral 57 Hypocalcemia 57 apnea hypopnea index 57 thrombocytopenia neutropenia 57 diastolic hypertension 57 CHD mortality 57 thrombotic events 57 supine hypertension 57 serum phosphorous 57 oxygen desaturation 57 MADRS score 57 fasting triglycerides 57 SCr 56 serum calcium levels 56 GOVERNMENT MEETINGS 56 lightheadedness dizziness 56 mcg BID 56 CIN3 56 fasting plasma glucose FPG 56 CRP marker 56 oral antidiabetic medication 56 hs CRP 56 echocardiographic parameters 56 plasma uric acid 56 specific antigen PSA 56 severely active polyarticular 56 mg BID 56 elevated LDH 56 T2 lesions 56 C Reactive Protein 56 tipranavir r 56 neurologic impairment 56 Febrile neutropenia 56 Acetate Rectal Suppositories 56 prednisone prednisolone plus 56 lymphopenia 56 #ppb gold 56 Orthostatic hypotension 56 HER2 expression 56 Chemotherapy induced 56 Hematologic toxicity 56 hyperlipemia 56 diabetes dyslipidemia 56 infliximab monotherapy 56 serum phosphate levels 56 tumor lysis syndrome 56 SUVmax 56 malignancy HCM 56 cutaneous manifestations 56 Hemolysis 56 tHcy 56 EXJADE 56 lumbar spine BMD 56 atheroma volume 56 plasma lipoprotein 56 refractory NSCLC 56 #.#mmol L [001] 56 mL/min/#.# m 2 56 dysuria 56 elevated creatinine 56 recurrent UTI 56 PRADAXA #mg 56 mmHg systolic 56 baseline HbA1c 56 impaired glucose metabolism 56 -#.# ± [002] 56 serum calcium 56 highest tertile 56 Mg Uk 56 subclinical hyperthyroidism 56 dapagliflozin plus 56 glomerular filtration rate 56 hemoglobin concentrations 56 apolipoprotein B 56 Syndrome RLS 56 severe renal impairment 56 serum parathyroid hormone 56 nonfatal MI 56 adjunctive placebo 56 LV ejection fraction 56 Non inferiority 56 morphometric vertebral fractures 56 mIU L 56 ARCOXIA 56 #.#mmol L [002] 56 HbA1C levels 56 hypoglycaemic episodes 56 MACCE 56 -#.# log# 56 nondiabetic patients 56 HbA 1C 56 HOMA IR 56 elevated LDL cholesterol 56 % Confidence Interval 56 GERD symptom 56 alanine transaminase ALT 56 Hypotension 56 pulmonary capillary wedge 56 fractional shortening 56 IIIa inhibitors 56 oxycodone IR 56 triiodothyronine 55 #.#mmHg 55 estimated glomerular filtration 55 plasma leptin 55 methylmalonic acid 55 HDL triglycerides 55 mmol l 55 mIU ml 55 0 document.write sline 55 certolizumab 55 ULORIC 55 LDL cholesterol HDL cholesterol 55 kg m² 55 HBeAg negative patients 55 nitrotyrosine 55 abdominal pain abdominal discomfort 55 colorectal adenoma 55 BENICAR HCT 55 MULTAQ 55 β blocker 55 subtrochanteric 55 density lipoprotein cholesterol HDL 55 virologic failure 55 anemia neutropenia 55 carotid stenosis 55 adjunctive ABILIFY 55 confirmed CCyR 55 geosynchronous orbit reached 55 tapentadol ER 55 iPTH 55 albumin excretion rate 55 urinary calcium excretion 55 subclinical hypothyroidism 55 elevated uric acid 55 microvessel density 55 somnolence sleepiness 55 Prostate Cancer Recurrence 55 Myelosuppression 55 nonvertebral fractures 55 FluCAM arm 55 transferrin saturation 55 nmol l 55 serum estradiol 55 PANHANDLE Temperatures 55 μmol L 55 advanced adenoma 55 REMICADE monotherapy 55 Index CDAI score 55 CR nPR 55 fluticasone salmeterol 55 mcg QD 55 fatal IHD 55 nmol L. 55 statistical significance p 55 CVD mortality 55 Serum creatinine 55 plasma folate 55 fasting glucose levels 55 #.#/#.# mm Hg [003] 55 serum phosphorus 55 vitreous floaters 55 NPH insulin 55 HBeAg seroconversion 55 anemia leukopenia 55 SELENA SLEDAI score 55 blood Phe levels 55 dizziness nausea diarrhea 55 calculated creatinine clearance 55 haematologic 55 IBDQ 55 plasma homocysteine levels 55 HF hospitalization 55 HBV DNA levels 55 Tumor shrinkage 55 tolvaptan 55 APTIVUS r 55 diastolic BP 55 #OHD levels 55 corticosteroid dose 55 clinically meaningful reductions 55 severe NCI CTC 55 hydroxyvitamin D levels 55 pulmonary arterial 55 Levels Linked 55 ° preoperatively 55 mL/min/#.# m2 55 HMG CoA reductase inhibitory 55 baseline A1C 55 Postoperative complications 55 mm Hg systolic 55 preoperative PSA 55 severe renal insufficiency 55 Thrombotic thromboembolic complications 55 thyrotropin levels 55 left ventricular systolic 55 cTnT levels 55 pg mL 55 Increased Mortality 55 serum vitamin D 54 XIENCE V vs. 54 Left Ventricular Ejection Fraction 54 serum lipid levels 54 extrapyramidal side 54 intravascular hemolysis 54 maximal doses 54 ertapenem 54 serum retinol 54 #μg [001] 54 mean baseline HbA1c 54 PaO 2 54 Atherosclerotic 54 hemoglobin A1c HbA1c 54 nmol liter 54 benazepril 54 candesartan cilexetil 54 N telopeptide 54 leukocyte counts 54 troponin T 54 Apolipoprotein B 54 primary hypercholesterolemia 54 LV dysfunction 54 proliferative diabetic retinopathy 54 gastric pH 54 nausea emesis 54 serum sodium 54 altitude cerebral edema 54 Arch Intern Med 54 sitosterol 54 mcg dL 54 serum selenium 54 moderate hepatic impairment 54 tapentadol IR 54 carotid IMT 54 Cerebrospinal Fluid 54 sUA levels 54 creatinine ratio 54 recurrent venous thromboembolism 54 #mm Hg 54 creatine kinase 54 recurrent ischemia 54 nonfasting triglyceride levels 54 Severe hypoglycemia 54 ATACAND 54 c reactive protein 54 hypovolemia 54 fasting insulin 54 gout flares 54 urinary cortisol 54 mm Hg diastolic 54 inflammatory biomarkers 54 hyperinsulinemia 54 cEVR 54 Severity Index PASI 54 overt nephropathy 54 residual platelet reactivity 54 maintaining Hb 54 salmeterol fluticasone propionate 54 pCR 54 ventricular dilatation 54 Knodell necroinflammatory score 54 serum PTH 54 mg TID 54 paraprotein 54 Dyslipidemia 54 HbA 1c levels 54 severe obstructive sleep 54 acute humoral rejection 54 microbleeds 54 Antioxidant Supplements 54 #R #R #R [002] 54 elevations 54 distensibility 54 periprocedural 54 XP# Transported Prodrug 54 binary restenosis 54 PSADT 54 atherosclerotic lesion 54 agitation hallucinations 54 systolic diastolic blood 54 #.#/#.# mmHg [001] 54 Thromboembolic 54 cerebrovascular events 54 placebo fluoxetine 54 erythrocyte sedimentation rate 54 urinary albumin excretion 54 fasting plasma glucose 54 cTnI 54 eosinophils echocardiogram serum troponin 54 glycated hemoglobin HbA1c 54 spirometric 54 Jingle spina bifida 54 subsyndromal 54 EDSS score 54 prolactin elevation 54 apolipoprotein E4 54 Hyperkalemia 54 CI #.#-#.# [001] 54 Operative mortality 54 neutrophil counts 54 HIV HCV coinfected 54 cytogenetic response 54 Soyabean Ext Bulk 54 apnea hypopnea 54 Ishak fibrosis score 54 % CI #.#-#.# [007] 54 hepatic lipase 54 NovoLog ® Mix 54 rizatriptan 54 PLX STROKE targeting 54 pCi l 54 p = NS 53 B7 H3 53 elevated liver enzymes 53 NR2B selective 53 fraction LVEF 53 myeloperoxidase 53 Furnishings Household 53 oxyhemoglobin 53 abnormal lipid 53 inhibin B 53 creatine phosphokinase 53 anginal pain 53 ritonavir boosted 53 piotr.skolimowski @ thomson.com 53 hematological parameters 53 thromboembolism 53 elevated LDL 53 Herpes infections 53 Montgomery Åsberg Depression 53 Montgomery Asberg Depression 53 renal dysfunction 53 -#.# mg dL [001] 53 Zometa hazard 53 osteopenic 53 inducible nitric oxide synthase 53 dose pravastatin 53 plasma cortisol 53 ® emtricitabine 53 thyrotropin 53 fibrosis scarring 53 glycated hemoglobin 53 fullyear outturn represents 53 triglyceride concentration 53 left ventricular dysfunction 53 plus OBT 53 asthma rhinitis 53 Hazard Ratio HR 53 postoperative AF 53 sustained virologic response 53 Svaliava 53 biochemical relapse 53 angina myocardial infarction 53 genital ulcers 53 neuropathy sensory 53 plasma lipid 53 Hypercholesterolemia 53 glomerular filtration 53 grade cervical intraepithelial 53 NIHSS 53 μg dL 53 serum insulin 53 Plasmodium infection 53 aminotransferase 53 CK # plasma 53 #OHD 53 + bornite veinlets 53 inflammatory acne 53 protein excretion 53 Comorbidities 53 μmol l 53 dysglycemia 53 isolated systolic hypertension 53 albumin excretion 53 arsenic antimony mercury 53 ACR# responses 53 CK # plasma concentrations 53 microalbuminuria 53 % CI #.#-#.# [006] 53 intima media thickness 53 erythema redness 53 Antidepressants Linked 53 serum HCV RNA 53 affective psychosis 53 confidence intervals CIs 53 Vertebral Fractures 53 gestational hypertension 53 BMI ≥ 53 ug kg 53 renal insufficiency 53 ADCS CGIC 53 elevated fasting glucose 53 baseline FEV1 53 IP chargeability 53 severe hepatic insufficiency 53 FDG uptake 53 events TEAEs 53 rs# [004] 53 #.#m #.#m #.#m [003] 53 neurologic dysfunction 53 cardiovascular mortality 53 plasma urate 53 fasting plasma 53 pmol L 53 plasma lipids 53 prospectively stratified 53 ecchymosis 53 NSAID induced GI 53 nonfatal stroke 53 fatigue frequent urination 53 elevated homocysteine 53 hypoglycemic episodes 53 pg ml 53 A1c levels 53 Hb A1C 53 arterial thickening 53 systolic dysfunction 53 bezafibrate 53 Severe Chronic Pain 53 PSA kinetics 53 hypercalciuria 53 dose Iluvien 53 Fasting plasma glucose 53 acetabular dysplasia 53 density lipoprotein cholesterol 53 CP CPPS 53 Cmax 53 Blood Clot Risk 53 homozygotes 53 fasting plasma insulin 53 urate lowering 53 NATRECOR ® 53 extrapyramidal symptoms EPS 53 triacylglycerol concentrations 53 visceral adiposity 53 serum ferritin 53 mg qd 53 systemic embolism 53 Severe Plaque Psoriasis 53 Abnormally Dry 53 hydroxymethyl coenzyme 53 ≥ 53 mg QD 53 Fracture Risk 53 intraventricular hemorrhage 53 DAS# scores 53 systolic BP 53 hemorrhagic complications 53 BMI #-#.# 53 triglyceride concentrations 53 tolterodine ER 53 #.#g/day 53 NNT = 53 Subclinical 53 virologic response 53 lymphocytosis 53 hemoglobin A1c levels 53 tirofiban 53 platelet reactivity 53 microbiological eradication 53 #mg/day [002] 53 hemodynamically significant 53 adenoma recurrence 53 serum bilirubin 53 WEST CENTRAL Temperatures 53 hematological toxicity 53 chlorambucil 53 hepatitis B immunoglobulin 53 isoprostane 53 prednisone prednisolone 53 pawel.sobczak @ thomson.com 53 #mg/dL [002] 53 tenderness clinical mastalgia 53 alkaline phosphatase 53 #mg/dl 53 HbA 1c 52 grade squamous intraepithelial 52 HBeAg 52 mL min 52 LUTS 52 DAS# [002] 52 mean ± SEM 52 AVODART 52 intermittent hypoxia 52 TLUS 52 recurrent atrial fibrillation 52 statin monotherapy 52 HBeAg negative 52 arterial oxygen saturation 52 #.#-#.# [011] 52 cervical intraepithelial neoplasia 52 abnormal glucose metabolism 52 metformin sulfonylurea 52 thyroid hormone levels 52 nonfatal myocardial infarction 52 Systolic 52 capillary leakage 52 urine NGAL 52 waist girth 52 Subclinical hypothyroidism 52 receiving ISENTRESS 52 QTcF 52 #mmHg [001] 52 mmol liter 52 luteinising hormone LH 52 Rectal cancer 52 progressive dyspnea 52 tertiles 52 serum creatinine 52 hematopoietic cancers 52 Severe Rheumatoid Arthritis 52 P = .# 52 g dl 52 permanently discontinue Vectibix 52 nonvertebral fracture 52 serum glucose 52 μg kg 52 Improves Outcomes 52 ruboxistaurin 52 #,#-#,# ft. Loc 52 umol L 52 LDL triglycerides 52 diabetes mellitus DM 52 autonomic dysfunction 52 Core Length 52 parasitaemia 52 unfractionated heparin UFH 52 fetal malformations 52 drilled thicknesses 52 natriuresis 52 primary Restless Legs 52 cardiovascular hospitalizations 52 Type IIa 52 CsA 52 Abdominal Fat 52 Neuroticism 52 EDARBI 52 LVEF 52 blood Phe 52 hormone receptor negative 52 QIDS SR 52 coronary artery calcification 52 serum sodium levels 52 increased storminess 52 serum concentrations 52 serum PSA 52 chronically immunosuppressed solid 52 concomitant medications 52 β blockers 52 gm dl 52 thyroid stimulating hormone 52 nmol L 52 -#.# ± [001] 52 atrophic gastritis 52 left ventricular LV 52 microalbumin test 52 Intraocular pressure 52 cells uL 52 metabolic disturbances 52 blood urea nitrogen 52 ADCS ADL 52 #.#ng/ml 52 antibody titers 52 Nonalcoholic fatty liver 52 arterial calcification 52 nicotine metabolite 52 clinically meaningful improvement 52 budesonide pMDI 52 cortisol secretion 52 NIH CPSI 52 hepatic insulin sensitivity 52 lispro 52 DISTANCE OF 52 Platelet counts 52 Follicular Lymphoma 52 NIASPAN 52 urate levels 52 fibrosis progression 52 symptomatic VTE 52 THENCE NORTH 52 Response Evaluation Criteria 52 confidence interval #.#-#.# 52 PRADAXA 52 Aggressive Prostate Cancer 52 posaconazole 52 IRLS score 52 recurrent VTE 52 lowest tertile 52 postoperative complication 52 Quartz veining 52 onset diabetes mellitus 52 rheumatoid factor 52 neoplasia PIN 52 serum bicarbonate 52 % CI #.#-#.# [004] 52 hsCRP 52 TC HDL 52 oral allopurinol 52 Tonight Cloudy 52 mg ustekinumab 52 albuminuria 52 lipid lowering agents 52 MMSE score 52 polyp recurrence 52 psychiatric comorbidities 52 fosamprenavir 52 BMI z 52 ACTOplus met 52 Elevated CRP 52 lens opacities 52 arterial thromboembolism 52 androgen depletion 52 elevated prolactin 52 Homebuilder sentiment 52 proliferative retinopathy 52 bothersome symptom 52 Nausea vomiting 52 Low birthweight 52 gallstone disease 52 asthma exacerbation 52 T2 lesion volume 52 QTc 52 fasting glucose 52 vincristine doxorubicin 52 PREZISTA ritonavir 52 ACR# response 52 peginterferon alfa 2a 52 Secondary endpoints 52 fasting hyperglycemia 52 metoprolol tartrate 51 HbA1c levels 51 creatinine levels 51 EBRT 51 Cholesterol Levels 51 irbesartan 51 malabsorptive 51 multivariate adjustment 51 Hyponatremia 51 Left Ventricular 51 Kidney Function 51 lifetime abstainers 51 coinfection 51 hsCRP levels 51 rebleeding 51 p = #.# [003] 51 ARIXTRA 51 LDL Cholesterol 51 lipid parameters 51 intrusive breccia bodies 51 poor metabolizers 51 mucosal inflammation 51 reduce visibilities 51 titrated glipizide 51 homocysteine concentrations 51 hedonically sic 51 sulcal 51 Plains northeastward 51 pT3 51 milliliter ng ml 51 Exclusion criteria 51 Tasigna prolongs 51 bloody diarrhea abdominal cramps 51 CIN2 51 retinal thickness 51 IDDM 51 nicardipine 51 overt hepatic encephalopathy HE 51 Forage availability 51 nonobese 51 NNRTI resistance 51 lumen diameter 51 irregular menstrual periods 51 biochemical recurrence 51 Insulin sensitivity 51 rs# [001] 51 hemoglobin Hb 51 lipohypertrophy 51 intracranial atherosclerosis 51 HDL cholesterol concentrations 51 quartz carbonate veining 51 hyperglycemia 51 neurodevelopmental impairment 51 UACR 51 #mg/day [001] 51 Postoperative 51 psoralen plus ultraviolet 51 Adiposity 51 leukocyte count 51 foberdieck@aercap.com pwortel@aercap.com 51 urinary N telopeptide 51 ml min 51 rs# [002] 51 serum albumin 51 advanced adenomas 51 severe hypoglycaemia 51 Calcium intake 51 Bone Mineral Density 51 gestational diabetes mellitus GDM 51 mg/m2 dose 51 corticosterone levels 51 μg d 51 EpCAM expression 51 HDL Cholesterol 51 mineral density 51 placebo p = 51 CIN2 + 51 μg g 51 constipating effects 51 #-#,# mg 51 dyspareunia 51 #.#m #.#m [004] 51 chronic urticaria 51 atorvastatin #mg 51 headaches dizziness disorientation nausea 51 Relative humidity 51 nmol 51 depressive symptomatology 51 Nagaland Manipur Mizoram Tripura 51 refractory ischemia 51 Stress Induced 51 airway hyper responsiveness 51 tissue oxygenation 51 desaturation 51 Coronary Artery Calcium 51 μg mL 51 stable angina 51 Hemoglobin A1c 51 serum lipid 51 salivary flow 51 tamsulosin 51 hyperphosphatemia elevated phosphate 51 Coleman Liau Coleman Liau 51 flutamide 51 intracerebral hemorrhages 51 impaired fasting glucose 51 nephrolithiasis 51 dietary calcium intake 51 endometrial thickness 51 venous thromboembolic disease 51 #mmHg [002] 51 Capacity FVC 51 #mg BID [001] 51 EMRG VIO 51 bacteriuria 51 Hemoglobin A1c HbA1c 51 #ng/ml 51 adiponectin concentrations 51 + PH# 51 asymptomatic carotid stenosis 51 diastolic pressures 51 http:/events.fai.org 51 cerebral infarctions 51 fasting triglyceride levels 51 ipsilateral stroke 51 FOLFOX4 alone 51 detrusor 51 oral hypoglycemic agents 51 % CI #.#-#.# [005] 51 HIV RNA 51 glycosylated hemoglobin 51 exhaled NO 51 tertile 51 renal flares 51 Diastolic 51 inversely associated 51 diameter stenosis 51 akinesia 51 periodically eg semiannually 51 thyroglobulin 51 cardiac malformations 51 IU mL 51 adrian.krajewski @ thomson.com 51 syncope fainting 51 BPH benign prostatic 51 -#.# log# copies mL 51 mean baseline A1C 51 carotid atherosclerosis 51 natriuretic peptides 51 Demographers attribute 51 unfavorable cytogenetics 51 Serum concentrations 51 squamous histology 51 Homocysteine levels 51 URTI 51 Fine particulate 51 Oxidized LDL 51 WOMAC pain 51 mmol L. 51 arterial hypotension 51 acarbose 51 ASCUS 51 steroid refractory ulcerative 51 elevated transaminases 51 elevated CRP 51 tryptase 51 Cognitive Decline 51 invasive carcinomas 51 progression TTP 51 enamel defects 51 glucose insulin 50 residual confounding 50 acromegalic patients 50 TOTAL REV 50 Severe Psoriasis 50 chloritization 50 Secondary endpoints include 50 mg dL 50 heterozygotes 50 ng dl